Nitric oxide as treatment for an emerging epidemic of obesity-related glomerulopathy

Diabetes Research and Clinical Practice

Volumn 74, Issue 2, 2006, Pages 207-208

  Ahmed, M H ^a   Khalil, A ^b   Osman, M M ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Insulin; Nitric oxide; Obesity related glomerulopathy

Indexed keywords

LEPTIN RECEPTOR; NITRIC OXIDE;

EPIDEMIC; GENE MUTATION; GLOMERULOPATHY; INSULIN RELEASE; INSULIN SENSITIVITY; KIDNEY INJURY; LETTER; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PATHOGENESIS; RISK FACTOR; SOYBEAN;

DIABETIC RETINOPATHY; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; NITRIC OXIDE; OBESITY;

EID: 33751102167     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.05.008     Document Type: Letter

References (5)

1. Wild S.H., and Byrne C.D. The global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. In: Byrne C.D., and Wild S. (Eds). Metabolic Syndrome (2005), Wiley & Sons Ltd., England 1-32
2. Kambham N., Markowitz G.S., Valeri A.M., Lin J., and D'Agati V.D. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 59 (2001) 1498-1509
3. Trujillo J., Ramirez V., Perez J., Torre-Villalvazo I., Torres N., Tovar A.R., Munoz R.M., Uribe N., Gamba G., and Bobadilla N.A. Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation. Am. J. Physiol. Renal Physiol. 288 (2005) 108-116
4. Schmidt R.J., and Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int. 58 (2000) 1261-1266
5. Ahmed M.H. Nitric oxide might be involved in the chloroquine-improved insulin sensitivity: old treatment for global danger. Diab. Res. Clin. Pract. 72 (2006) 110-111